Iron supplement in cancer patients receiving erythropoietin.
Pedrazzoli
Paolo
P
Tullio
Cinzia
C
Cerea
Giulio
G
Siena
Salvatore
S
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000008:administration & dosage*; D007505:Iron-Dextran Complex / Q000008:administration & dosage*; D009369:Neoplasms / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D007505:Iron-Dextran Complex; D007501:Iron